Showing results (221-230 of 230) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 230 results.
The Journal of Endocrinology|September 1, 1992
Oestrogen enhancement of the myometrial response to exogenous parathyroid hormone-related protein (PTHrP), and tissue localization of endogenous PTHrP and its mRNA in the virgin rat uterusV Paspaliaris, S J Vargas, M T Gillespie, et al.
British Journal of Cancer|June 2, 2005
Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colonE T Donnelly, H Bardwell, G A Thomas, et al.
Molecular Carcinogenesis|May 23, 2000
Development of a prostate cDNA microarray and statistical gene expression analysis packageA J Carlisle, V V Prabhu, A Elkahloun, et al.
British Journal of Cancer|May 20, 2004
Thyroid carcinoma after Chernobyl latent period, morphology and aggressivenessE D Williams, A Abrosimov, T Bogdanova, et al.
Clinical Science (London, England : 1979)|September 1, 1982
Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertensionC Beretta-Piccoli, D L Davies, K Boddy, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 1999
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variantG A Thomas, H Bunnell, H A Cook, et al.
Oncogene|September 20, 2016
Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6APP J Paul, D Raghu, A-L Chan, et al.
British Journal of Cancer|January 26, 2000
Gene rearrangement and Chernobyl related thyroid cancersM Santoro, G A Thomas, G Vecchio, et al.
British Journal of Cancer|March 20, 2008
The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitroP M O'Brien, M J Davies, J P Scurry, et al.
Oncogene|January 17, 2017
Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortalityB W C Tse, M Volpert, E Ratther, et al.
Pageof 23